Stiripentol

司替戊醇

Report date: 2026/05/25 20:02:40
NME

Base Information

Drug NameStiripentol
Drug Alias NameDiacomitME-2080BCX-2600
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonistsL-lactate dehydrogenase inhibitors
TargetsGamma-aminobutyric acid A receptorL-lactate dehydrogenase
Therapy Area/IndicationsPrimary Hyperoxaluria Type 1Renal Insufficiency, ChronicHyperoxaluria, Primary +[7] 
Global Approved IndicationsMyoclonic Epilepsy, JuvenileEpilepsies, Myoclonic
Approved Indications in ChinaEpilepsies, Myoclonic
Original Approved Country/TerritoryEU
Original Approved Date2007/01/03
Country/TerritoryBelgiumBulgariaUnited States +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBiocodex Sa
China Registration ClassN/A

Develop Information

Active CompaniesMeiji Seika PharmaMoksha8 Pharmaceuticals IncBiocodex Sa +[4] 
Inactive CompaniesN/A
Active IndicationsPrimary Hyperoxaluria Type 1Renal Insufficiency, ChronicHyperoxaluria, Primary +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN03AX17
Related LinksWikipediaDrugBankKEGG